Navigation Links
Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
Date:12/14/2007

BALTIMORE, Dec. 14 /PRNewswire/ -- Alba Therapeutics Corporation announced today that it has entered into a strategic collaboration with Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ), to jointly develop AT-1001, Alba's lead inhibitor of barrier dysfunction in various gastrointestinal ("GI") disorders. Shire will receive rights to commercialize all forms of AT-1001 outside of the United States and Japan. Alba will retain all rights to commercialize AT-1001 in the United States and Japan.

Under the terms of the collaboration, Alba will receive an initial, non- refundable licensing payment of US$ 25 million. Joint development costs toward global approval of AT-1001 will be shared 50/50 after the completion of two Phase 2 studies for Celiac disease. Alba is eligible to receive over US$ 80 million if certain clinical, regulatory and launch milestones are met for certain GI indications. Additional milestone payments totaling over US$ 40 million per indication will also be payable to Alba if the Collaboration is expanded beyond GI indications. Alba is also eligible to receive up to US$ 220 million in sales-based milestones, as well as tiered royalties. Not including royalties and cost sharing, the deal is valued at over US$ 325 million if all milestones are achieved.

Dr. Blake M. Paterson, Alba's President & CEO said:

"We are pleased to enter into this partnership with Shire, which leverages the unique experience and expertise of both companies in developing therapies for GI disorders. The combination of Alba's barrier function technology and autoimmune development capabilities with Shire's proven track record in GI drug development and commercialization will greatly enhance our efforts to bring these novel therapies to patients."

Matthew Emmens, Shire's CEO said:

"Alba's products have the potential to be an excellent addition to our current gastrointestinal business. This technology should provide significant benefit to patients w
'/>"/>

SOURCE Alba Therapeutics Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... METTLER TOLEDO recently announced tha...s Optimization Using At-Line Particle Characteriza.... In this webinar, the application of in situ par...design space and optimize a series of roller compa..., and roller compaction forces. , ...
(Date:11/19/2009)...le would like to be able to charge their cell phon...too often. A recent discovery made by UC San Diego...ercapacitors that could do just this. , In rece... , Prabhakar Bandaru, a professor in the UCSD Depa...ong with graduate student Mark Hoefer, have found ...
(Date:11/19/2009)...ATTLE, Nov. 19 Omeros Co...ed financial results for the third quarter ended S...ember 30, 2009, Omeros reported a net loss of $3.9... loss of $7.4 million, or $2.54 per share, for the...ptember 30, 2009, the Company reported a net loss ...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-First... innovator in biotechnology for diabetes therapy, ...ing services to food, supplement, biotechnology an...sed the previously reported $6.3 million registere...,760,870 shares of its common stock and warrants t...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2Nanotube defects equal better energy and storage systems 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
...kfield-based Norlight Telecommunications has int...portfolio, a disaster-recovery facility for fallba...omers with a secure back-up facility, available ar...placed employees can temporarily go to work at the...off by a disasters such as a power outage, severin...
...vision the city of the future. Is it a "sustainabl...ly made its way eastward across the Atlantic and i...ou count the number of dedicated Web pages, mayors...attendees are investing to learn about sustainabil...anically, of course everywhere you look. , ,Are "...
...ness incubators are nothing new to Wisconsin the ... them are using a new round of state grants to inj...he Wisconsin Department of Commerce has awarded 26...,s Community Based Economic Development (CBED) and.... Many of the grant winners are existing business ...
Other Biology Technology:Building sustainable cities 2Building sustainable cities 3Building sustainable cities 4Grant winners hope to cultivate job-creating tech businesses 2Grant winners hope to cultivate job-creating tech businesses 3
(Date:11/20/2009)...ity of Oklahoma researchers were sequencing the fi...roject. Today, the OU Advanced Center for Genome...fort to sequence the tomato genome with a $7.5 mil...ion for plant genomics. , "The tomato has treme...ato and crop yields will improve quality of life,"...
(Date:11/20/2009)...of biological molecules like RNA and DNA is how th...simple precursors. Now, in a study appearing in th...cted one of the earliest evolutionary steps yet: g...its using nothing but warm water. , Many resear...ical molecules present, before DNA and proteins; h...
(Date:11/20/2009)...e bacterial gene into yeast, researchers from Delf...eved three improvements in bioethanol production f...ss acetate and elimination of the major by-product...n the scientific journal Applied and Environmenta...made by the yeast Saccharomyces cerevisiae from su...
Breaking Biology News(10 mins):NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Delft breakthrough in bioethanol production from agricultural waste 2Over 2 200 veterans died in 2008 due to lack of health insurance 61079 1Over 2 200 veterans died in 2008 due to lack of health insurance 61079 2Winners of the 2009 AAAS Kavli science journalism awards 10673 1Winners of the 2009 AAAS Kavli science journalism awards 10673 2Winners of the 2009 AAAS Kavli science journalism awards 10673 3Winners of the 2009 AAAS Kavli science journalism awards 10673 4Winners of the 2009 AAAS Kavli science journalism awards 10673 5Winners of the 2009 AAAS Kavli science journalism awards 10673 6Winners of the 2009 AAAS Kavli science journalism awards 10673 7Winners of the 2009 AAAS Kavli science journalism awards 10673 8Common Infections May Contribute to Strokes 61075 1Common Infections May Contribute to Strokes 61075 2Common Infections May Contribute to Strokes 61075 3
...- Tougher teeth . . . , Artificial teeth and cr...usually within six to 10 years but that may chang... A group led by Claus Daniel of Oak Ridge National...sion has discovered that a high-speed periodic las...urface structure. Nowadays, cracks begin at the in...
...rcury is a potent neurotoxin and a worrisome envir...at appears to depend on what else is in the water....ison have found that the presence of dissolved org...eous mercury and may even serve as an environmenta...t the environment in small quantities in rocks and...
...eth, neck injuries and abrasions in the mouth, als...r present among athletes. According to the U.S. Ce...njuries account for more than 600,000 emergency ro...guards should serve as a preventive measure. In so...nown to avert oral injuries and cut the risk of co...
Other Biology News:Story tips from the Department of Energy's Oak Ridge National Laboratory, December 2007 2Story tips from the Department of Energy's Oak Ridge National Laboratory, December 2007 3Waterborne carbon increases threat of environmental mercury 2To keep mouths safe, don't just wear a mouthguard; keep it clean 2
Rabbit Anti-Shh Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Mouse Anti-Cohesin (Scc1 / Rad21) Monoclonal Antibody, Unconjugated, Clone CM110-2C10 from MBL International
Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam
Rabbit Anti-melatonin Antibody, Unconjugated from Cell Sciences
Biology Products: